Stay updated on Fc-Engineered Anti-CTLA-4 in Advanced Cancer Clinical Trial
Sign up to get notified when there's something new on the Fc-Engineered Anti-CTLA-4 in Advanced Cancer Clinical Trial page.

Latest updates to the Fc-Engineered Anti-CTLA-4 in Advanced Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe site footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check8 days agoChange DetectedA banner announces NIH website changes and says federal agencies are using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) during the transition.SummaryDifference0.5%

- Check14 days agoChange DetectedThe ClinicalTrials.gov footer revision identifier changed from v3.7.1 to v3.7.2; the study history content remains unchanged.SummaryDifference0.1%

- Check21 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check42 days agoChange DetectedThe study record history now includes a new version entry, Revision: v3.7.0, indicating an update to the page; the previous revision, v3.6.6, has been superseded.SummaryDifference0.1%

- Check64 days agoChange DetectedA new revision entry, v3.6.6, has been added to the record history, replacing the previous v3.6.5. This indicates a small update to the page's release notes rather than a substantive change to the study information.SummaryDifference0.1%

Stay in the know with updates to Fc-Engineered Anti-CTLA-4 in Advanced Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fc-Engineered Anti-CTLA-4 in Advanced Cancer Clinical Trial page.